Finasteride Tablet, Film Coated
Product Images NDC 71335-1634

6 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 71335-1634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Finasteride Fig 1)

Structure (Finasteride Fig 1)
Chemical structure of finasteride, showing its steroid-like fused ring system with associated functional groups, including a keto group and an amide substituent.*
FDA Label Image

Image Of Figure 1 (Finasteride Fig 2)

Image Of Figure 1 (Finasteride Fig 2)
A line graph depicting the mean change from baseline plus or minus one standard error over a four-year period for two groups: Finasteride and Placebo. The x-axis shows time points from baseline through year 4, while the y-axis represents the mean change. Two lines illustrate changes for the Finasteride group and the Placebo group, with sample sizes listed below each time point.*
FDA Label Image

Image Of Figure 2 (Finasteride Fig 3)

Image Of Figure 2 (Finasteride Fig 3)
A line graph comparing the percent of patients over observation time in months between Finasteride and placebo groups. The graph shows cumulative events over time. Below the graph, a table lists cumulative events and number of patients at risk per year for each group.*
FDA Label Image

Image Of Figure 3 (Finasteride Fig 4)

Image Of Figure 3 (Finasteride Fig 4)
A line graph showing mean percent change from baseline plus one standard error in two groups over four years. One group (placebo) shows a declining trend, while the other shows an increasing trend. The x-axis represents time from baseline to year 4, and the y-axis measures mean percent change from baseline.*
FDA Label Image

Image Of Figure 4 (Finasteride Fig 5)

Image Of Figure 4 (Finasteride Fig 5)
A line graph depicting the percent of participants with an event over 5.5 years from randomization for four groups: Placebo, Finasteride, Doxazosin, and Combination. The y-axis shows percent with event from 0 to 25%, and the x-axis shows years from 0 to 5.5. Placebo has the highest event rate, followed by Finasteride, Doxazosin, and Combination with the lowest.*
FDA Label Image

Label Image (Lbl713351634)

Label Image (Lbl713351634)
Finasteride 5 mg film-coated tablet label by Bryant Ranch Prepack, Burbank, CA. The label references comparison to Proscar 5 mg tablet by Intas Pharmaceuticals Limited. It includes storage instructions at room temperature 20°-25°C (68°-77°F), a barcode, and NDC 71335-1634. Package count is 100 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.